Amneal Pharmaceuticals, Inc. (FRA:2DT)
Germany · Delayed Price · Currency is EUR 10.50
+0.10 (0.96%)
Last updated: Dec 1, 2025, 3:29 PM CET
Amneal Pharmaceuticals Market Cap
Amneal Pharmaceuticals has a market cap or net worth of €3.33 billion as of December 1, 2025. Its market cap has increased by 23.23% in one year.
Market Cap
3.33B
Enterprise Value
5.52B
Revenue
2.50B
Ranking
n/a
PE Ratio
661.98
Stock Price
€10.50
Market Cap Chart
Since May 7, 2018, Amneal Pharmaceuticals's market cap has increased from 1.60B to 3.33B, an increase of 108.14%. That is a compound annual growth rate of 10.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 3.39B | 43.20% |
| Dec 31, 2024 | 2.37B | 40.80% |
| Dec 29, 2023 | 1.68B | 496.83% |
| Dec 30, 2022 | 282.05M | -55.17% |
| Dec 31, 2021 | 629.13M | 14.07% |
| Dec 31, 2020 | 551.54M | -4.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |